Treatment and Prevention of Osteoporosis during COVID-19

Over the last several months, an unique Coronavirus (COVID-19) pandemic has been reported in 219 nations, regions, or territories throughout the world, posing major health risks. The incubation time for viruses ranges from 2 to 14 days. Patients with osteoporosis have been found to be at a higher risk of developing COVID-19-related complications. Osteoporosis is a long-term disease that weakens bones and raises the risk of fracture. To limit the risk of future bone loss, structural integrity deterioration, and fractures, osteoporosis usually need long-term treatment. The identification of persistent osteoporosis issues should not be an unwelcome victim of the COVID-19 epidemic. In COVID-19 infected people, metabolic bone disease can cause difficulties. COVID-19 infected individuals are being treated by orthopaedic doctors who have been reassigned to other facilities. As a result, mandatory training for orthopaedics is required to grasp the signs of this illness. In a hospital setting with limited medical personnel and operating facilities, orthopaedic surgery and trauma surgery are difficult to perform. Clinicians must address the challenges posed by the crisis and explore how to continue to assist patients with chronic conditions in reducing morbidity and death

    Related Conference of Treatment and Prevention of Osteoporosis during COVID-19

    November 13-14, 2024

    33rd International Diabetes and Healthcare Conference

    Paris, France
    November 18-19, 2024

    7th Annual Meeting on Diabetes and Endocrinology

    Paris, France
    November 18-19, 2024

    3rd International Summit on Hormonal Disorders

    Madrid, Spain
    November 22-23, 2024

    20th World Congress on Endocrinology & Diabetes

    Amsterdam, Netherlands
    November 26-27, 2024

    33rd International Conference on Clinical Diabetes, Diabetic Medication & Treatment

    Paris, France
    November 27-28, 2024

    14th World Congress on Endocrinology and Diabetes

    Paris, France
    January 27-28, 2025

    29th International Conference on Diabetes, Endocrinology and Healthcare

    Dubai, UAE
    February 24-25, 2025

    34th European Diabetes Congress

    London, UK
    February 24-25, 2025

    20th International Conference on Endocrinology and Metabolic Disorders

    London, UK
    March 10-11, 2025

    18th European Diabetes and Endocrinology Congress

    Rome, Italy
    March 10-11, 2025

    4th Global Summit on Physiology and Metabolism of Thyroid

    Singapore City, Singapore
    March 17-18, 2025

    19th International Conference on Endocrinology, Diabetes and Metabolism

    Singapore City, Singapore
    March 17-18, 2025

    5th European Endocrinology and Diabetes Congress

    Paris, France
    March 24-25, 2025

    6th Global summit on Diabetes and Endocrinology

    London, UK
    April 07-08, 2025

    36th International Congress on Prevention of Diabetes and Complications

    Vancouver, Canada
    April 10-11, 2025

    31st International Conference on Human Metabolic Health- Diabetes, Obesity & Endocrinology

    Dubai, UAE
    April 10-11, 2025

    5th World Congress on Endocrine and Diabetes

    Dubai, UAE
    April 10-11, 2025

    27th World Congress on Diabetes and Endocrine Disorders

    Dubai, UAE
    May 05-06, 2025

    24th International Conference on Diabetes, Nutrition, Obesity and Eating Disorders

    Rome, Italy
    May 12-13, 2025

    2nd International Congress on Endocrinology and Complications of Diabetes

    Rome, Italy
    May 19-20, 2025

    6th World Summit on Diabetes

    Rome, Italy
    June 04-05, 2025

    4th World Congress on Diabetes and Pediatric Endocrinology

    Edinburgh, Scotland
    June 24-25, 2025

    23rd Global Conference on Diabetes, Endocrinology and Primary Healthcare

    Paris, France

    Treatment and Prevention of Osteoporosis during COVID-19 Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in